Name: Hexarelin 2mg - Template
Price: 19.95 USD
Availability: InStock

Overview

Hexarelin 2 mg (aka Examorelin) from Peptide Tech is a premium, lyophilized research-use-only (RUO) peptide supplied at ≥99% purity (HPLC & MS verified). This synthetic hexapeptide (His-D-2-Me-Trp-Ala-Trp-D-Phe-Lys-NH₂) is a selective agonist of the GHSR1a receptor and is widely used in in-vitro receptor-signaling, calcium-mobilization, and ligand-binding workflows.

Specifications

Property	Details
CAS Number	140703-51-1
Chemical Name	L-Histidyl-2-methyl-D-tryptophyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide (Examorelin)
PubChem CID	6918297
Molecular Formula	C₄₇H₅₈N₁₂O₆
Molecular Weight	~887.04 g/mol
Physical Appearance	White to off-white lyophilized powder
Sequence	His-D-2-Me-Trp-Ala-Trp-D-Phe-Lys-NH₂
Container	3 mL glass vial (2 mg net content)
Purity	≥99% verified by HPLC & MS (lot COA via QR)
Solubility	Water-soluble; optimize buffer and pH for your assay. Reference
Intended Use	Laboratory research only. Not for human or animal use.

Molecular Structure

Key Features of Peptide Tech

Same-Day Shipping (Mon–Fri, on in-stock items)
GMP-Aligned Lyophilized Peptides
USA Made
24/7 Support
Price Match Guarantee
Batch Tracking with QR Code Verification
3rd-Party U.S. Lab Testing — purity, quantity, endotoxin
Cold-Chain Shipping — Always (no paid upgrade)
Worldwide Shipping
All Major Payments Accepted
Text & Email Order Updates
2-Day FedEx/UPS Shipping Standard
Cheapest Overnight Rates
Largest Variety of Peptides & Bioregulators

Potential Applications in Research

Strictly in-vitro, cell-based, or biochemical experiments. No health claims or clinical/veterinary use.

GHSR1a calcium-mobilization assays in GHSR-expressing cells (e.g., CHO/HEK293) using fura-2 or GECI readouts to quantify agonist potency and acute receptor desensitization.
Receptor internalization & beta-arrestin recruitment (confocal/BRET/ELISA) to profile GHSR1a trafficking and biased signaling after exposure.
Radioligand & competition binding using iodinated analogs for saturation and competition binding in membrane preparations.
Pathway mapping (e.g., PLC/IP3–Ca2+, ERK/Akt) in heterologous or pituitary-derived lines to dissect downstream signals after GHSR1a activation.
Analytical method development (LC–MS/MS) for detection and quantitation of hexarelin and related GHRPs in lab matrices.

Quality, Storage & Handling

Every lot is confirmed by HPLC (purity) and MS (identity); batch-level COA is accessible via on-vial QR. Third-party U.S. laboratories verify purity, quantity, and endotoxin.

Storage (lyophilized): −20 °C long term or 2–8 °C short term; keep desiccated and light-protected.
After reconstitution: Aliquot and store at ≤−20 °C; avoid repeated freeze–thaw cycles.
Reconstitution tips: Use sterile water or suitable buffer; gentle inversion/brief sonication can aid dissolution; filter-sterilize if required.

Shipping & Fulfillment

Ships with validated cold-chain packaging. In-stock orders placed before the daily cutoff ship the same day. 2-Day FedEx/UPS is standard, with overnight options available. Automated text/email updates included; international shipping available where permitted.

Compliance & RUO Disclaimer

For laboratory research only. Not a drug, cosmetic, food, or household chemical. Not for human or animal use, clinical, veterinary, or diagnostic applications. Buyers warrant they are qualified to handle RUO materials per applicable laws and institutional guidelines.

FAQs

Is this for human or veterinary use?: No. This product is sold strictly as RUO and must not be used in humans or animals.
What purity do you provide?: Each 2 mg vial is ≥99% by HPLC with MS identity confirmation; third-party testing is performed on every lot (see COA via QR).
How should I reconstitute it?: Use sterile water or compatible buffer; gently invert until dissolved. If your protocol requires, 0.22 µm filter-sterilize and aliquot.
What in-vitro assays is Hexarelin commonly used in?: Typical RUO uses include GHSR1a Ca2+ signaling, receptor internalization/beta-arrestin studies, radioligand binding, and LC–MS/MS method development.